HOME >> MEDICINE >> NEWS
Clinical trial of Etanercept for Wegener's disease shows no benefit

A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, is a common treatment for rheumatoid arthritis and other types of joint inflammation.

"We had hoped that this approach to the treatment of Wegener's granulomatosis would be useful in preventing disease relapses," says John H. Stone, M.D., associate professor of medicine, director of the Johns Hopkins Vasculitis Center, and lead investigator of the study published in the Jan. 27, 2005, issue of the New England Journal of Medicine.

"The study results, however, demonstrate unequivocally that etanercept was not effective for this purpose. Because of the disease's propensity to flare following remission and the high risk of treatment complications associated with conventional therapies for Wegener's, we must continue to look for safe, effective ways of achieving and maintaining disease remissions," said Stone.

Wegener's granulomatosis is an uncommon disorder in which the body's immune system attacks its own blood vessels, damaging vital organs by limiting the flow of blood to lungs, kidneys, upper airways and other organs. The disease can affect people of any age and occurs in men and women with equal frequency.

Although current medications used to treat Wegener's halt the disease temporarily in most patients, 60 to 80 percent of patients eventually suffer from disease flares. The need to treat many patients repeatedly with medications such as glucocorticoids (prednisone), cyclophosphamide, and methotrexate leads to mounting morbidity from treatments. At the same time, each disease flare has the potential to cause irreversible damage. Wegener's granulomatosis frequently leads to kidney failure, hearing loss, damage to the respiratory tract, peripheral nerve injury, and other complications, according to Stone.

Etanercept, the f
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
26-Jan-2005


Page: 1 2 3

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial participants fare no better, no worse than other patients
3. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
4. National Academies news: Clinical research involving children
5. Clinical research key in advance to prospective health care
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 graduate of Trident ... the health benefits of coconut oil in the 7 November 2019 edition of ... Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. Santos, examines the ...
(Date:12/5/2019)... SEATTLE (PRWEB) , ... December 05, 2019 , ... ... higher education planning, has announced the Top 54 RHIT Degree Programs for 2020. ... and universities in the nation. Each program is evaluated based on curriculum quality, ...
(Date:12/4/2019)... ... December 04, 2019 , ... Now ... provides protection from disruptions to cells and tissue and inflammation that leads to ... Lag, is available in a dietary supplement product called Prepair™ . , ...
(Date:12/4/2019)... and CHAPEL HILL, N.C. (PRWEB) , ... December 04, 2019 , ... ... patients and their families easily find their way around the campuses of UNC Medical ... turn-by-turn navigation inside the two hospitals, parking garages, clinics and more. , The free ...
(Date:12/2/2019)... Fla. (PRWEB) , ... December 02, 2019 , ... ... is a silver winner of the 2019 Workforce: Optimas Awards . Selected for ... is first and foremost to help combat the nation’s caregiver shortage. By 2025, the ...
Breaking Medicine News(10 mins):
(Date:11/27/2019)... ... November 27, 2019 , ... ... to help those suffering from extreme dry skin disorders. Urea is a natural ... ingredient provides intensive hydration to restore moisture balance for consumers with very dry ...
(Date:11/27/2019)... ... November 27, 2019 , ... A November 7 article on ... on looking festive in a creative way for holiday photos and get-togethers. The looks ... application of tiny rhinestones around the eyes to achieve an ornamental aesthetic. Los Angeles-based ...
(Date:11/23/2019)... ... ... For the third year in a row, Shaw Industries Group, Inc. (Shaw) ... in addition to showcasing a test installation of an innovative new trade show carpet ... Floors Builder Group brands. , Shaw offered five CEU-credit approved education sessions in its ...
Breaking Medicine Technology:
Cached News: